Stockreport

MaxCyte outlines $17M–$19M annualized savings through restructuring while reiterating SPL revenue guidance [Seeking Alpha]

MaxCyte, Inc.  (MXCT) 
PDF CEO Maher Masoud reported $6.8 million in total revenue for the third quarter, including $6.4 million in core revenue and $0.4 million in SPL program-related revenue, n [Read more]